fr   en
Clinical Studies

Browse by date
Or search by keyword
Date: 2010-08-04
Phase: I
Anouncement: Launch
Biotech: Glycotope (Germany)
Product: CetuGEX™ (GT-MAB 5.2-GEX)
Disease: Various solid cancers
Country: Germany, Italy
Other: Glycotope has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s antibody CetuGEX™ (GT-MAB 5.2-GEX) for the treatment of various solid cancers.